Literature DB >> 21242329

Changes of B and T lymphocytes and selected apopotosis markers in Hashimoto's thyroiditis.

Elzbieta Kaczmarek1, Katarzyna Lacka, Donata Jarmolowska-Jurczyszyn, Anna Sidor, Przemyslaw Majewski.   

Abstract

The aim was to assess changes of B and T lymphocytes and selected apoptotic markers in Hashimoto thyroiditis (HT) cases on the basis of quantitative immunohistochemical studies (CD20, CD43, CD8, Bcl-2, caspase-3). The control group comprised colloid goitres without inflammatory infiltrate taken from 10 female patients. Thyroid specimens were obtained retrospectively from 40 patients. The immunohistochemical reactions were subject to quantitative evaluation performed using image-processing methods, including a spatial visualisation of the markers' expression. The percentage of Bcl-2 reactions in HT (mean 3.65%, SD 2.94%) was significantly lower than in the control group (mean 13.99%, SD 5.04%), while the thyroid follicles in HT samples exhibited a higher degree of staining for caspase-3 (mean 1.10%, SD 1.03%) in contrast to normal control tissues (mean 0.48%, SD 1.02%). The results from this study indicate that apoptosis plays a major role in the patogenesis of autoimmune thyroid diseases containing the main pathogenic events in the lesion of thyroid follicular cells in HT. Moreover, the reactivity of CD43 and CD20 was significantly higher in Hashimoto disease, while CD8 was not significantly different from the control group.

Entities:  

Mesh:

Year:  2011        PMID: 21242329     DOI: 10.1136/jcp.2010.086553

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Role of B cells in presentation of autoantigens to CD4(+) T cells in patients with autoimmune thyroiditis.

Authors:  E M Kuklina; E N Smirnova; I V Nekrasova; T S Balashova
Journal:  Dokl Biol Sci       Date:  2015-11-04

2.  Neuroprotective effect of (-)-epigallocatechin-3-gallate on autoimmune thyroiditis in a rat model by an anti-inflammation effect, anti-apoptosis and inhibition of TRAIL signaling pathway.

Authors:  Junfeng Li
Journal:  Exp Ther Med       Date:  2017-11-14       Impact factor: 2.447

3.  Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease.

Authors:  Y Arakawa; M Watanabe; N Inoue; M Sarumaru; Y Hidaka; Y Iwatani
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

4.  Hashimoto's Thyroiditis: From Genes to the Disease.

Authors:  Katja Zaletel; Simona Gaberšček
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

5.  Vitamin D Receptor Gene Polymorphisms and Autoimmune Thyroiditis: Are They Associated with Disease Occurrence and Its Features?

Authors:  Adam Maciejewski; Michał J Kowalczyk; Waldemar Herman; Adam Czyżyk; Marta Kowalska; Ryszard Żaba; Katarzyna Łącka
Journal:  Biomed Res Int       Date:  2019-08-21       Impact factor: 3.411

6.  AATF and SMARCA2 are associated with thyroid volume in Hashimoto's thyroiditis patients.

Authors:  Luka Brčić; Ana Barić; Benjamin Benzon; Marko Brekalo; Sanda Gračan; Dean Kaličanin; Veselin Škrabić; Tatijana Zemunik; Maja Barbalić; Ivana Novak; Valdi Pešutić Pisac; Ante Punda; Vesna Boraska Perica
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

7.  Peripheral blood lymphocyte apoptosis and its relationship with thyroid function tests in adolescents with hyperthyroidism due to Graves' disease.

Authors:  Maria Klatka; Ewelina Grywalska; Agata Surdacka; Jerzy Tarach; Janusz Klatka; Jacek Roliński
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

8.  Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves' Disease.

Authors:  Jessica Castro de Vasconcelos; Icléia Siqueira Barreto; Patrícia Sabino Matos; Frederico Fernandes Ribeiro Maia; Marcos Antônio Tambascia; Maria Cândida Ribeiro Parisi; Denise Engelbrecht Zantut-Wittmann
Journal:  Int J Endocrinol       Date:  2018-06-19       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.